MarketCap
Facebook
X
TelegramAphria Inc. Total Current Liabilities 2011-2026 | APHA
Annual Total Current Liabilities Aphria Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 170 M | 139 M | 43.9 M | 10.3 M | 1.27 M | 947 K | 30 K | 11 K | 11 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 170 M | 11 K | 40.6 M |
Total Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acer Therapeutics
ACER
|
19 M | - | 2.71 % | $ 14 M |  USA |
 |
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | USA |
 |
AgeX Therapeutics
AGE
|
5.91 M | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | USA |
 |
AbCellera Biologics
ABCL
|
64.3 M | $ 3.63 | -2.16 % | $ 1.08 B |  Canada |
 |
I-Mab
IMAB
|
576 M | - | - | $ 866 M |  China |
 |
ADMA Biologics
ADMA
|
69.5 M | $ 16.54 | 0.98 % | $ 3.94 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | USA |
 |
Apellis Pharmaceuticals
APLS
|
324 M | $ 19.86 | -1.49 % | $ 2.51 B | USA |
 |
Aptorum Group Limited
APM
|
4.34 M | $ 0.83 | 4.19 % | $ 4.53 M | China |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | USA |
 |
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | USA |
 |
Alpine Immune Sciences
ALPN
|
58 M | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | USA |
 |
ANI Pharmaceuticals
ANIP
|
194 M | $ 76.53 | 0.57 % | $ 1.48 B | USA |
 |
Applied Therapeutics
APLT
|
71.2 M | - | - | $ 8.42 M | USA |
 |
Aravive
ARAV
|
22.1 M | - | -13.39 % | $ 1.45 M | USA |
 |
Adverum Biotechnologies
ADVM
|
22.9 M | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - |  Russia |
 |
Cabaletta Bio
CABA
|
16 M | $ 3.43 | 5.54 % | $ 4.01 M | USA |
 |
Athersys
ATHX
|
29.9 M | - | 3.77 % | $ 22.4 M | USA |
 |
ARCA biopharma
ABIO
|
13 M | - | 1052.0 % | $ 415 M | USA |
 |
AVEO Pharmaceuticals
AVEO
|
18.7 M | - | - | $ 521 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
166 M | $ 35.69 | 1.16 % | $ 3.71 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
147 M | $ 24.69 | 3.22 % | $ 3.02 B | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
31.9 M | $ 8.42 | 2.56 % | $ 36.4 M | USA |
 |
Axsome Therapeutics
AXSM
|
379 M | $ 164.08 | 0.02 % | $ 8.16 B | USA |
 |
CorMedix
CRMD
|
11.4 M | $ 7.12 | 3.04 % | $ 362 M | USA |
 |
Champions Oncology
CSBR
|
23.9 M | $ 6.0 | - | $ 82 M | USA |
 |
Citius Pharmaceuticals
CTXR
|
35.8 M | $ 0.82 | 10.34 % | $ 5.52 M | USA |
 |
BridgeBio Pharma
BBIO
|
288 M | $ 66.54 | 3.11 % | $ 12.7 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
8.98 M | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
82.4 M | - | -4.8 % | $ 255 M | USA |
 |
Acasti Pharma
ACST
|
1.93 M | - | 4.01 % | $ 150 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
1.83 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Denali Therapeutics
DNLI
|
102 M | $ 20.37 | 1.75 % | $ 3.35 B | USA |
 |
Edesa Biotech
EDSA
|
1.83 M | $ 4.27 | -1.84 % | $ 13.7 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
3.77 M | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
45.5 M | - | -7.31 % | $ 87 M | USA |
 |
Equillium
EQ
|
27.6 M | $ 1.75 | -1.13 % | $ 60.8 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
5.4 M | - | -74.18 % | $ 955 K | USA |